The impact of age at initial HPV vaccination on cervical cancer screening participation in a nationally representative cohort of women in the United States.

Objective: A better understanding of factors associated with cervical cancer screening can inform strategies for cervical cancer prevention. This study examined the relationship between age at human papillomavirus (HPV) vaccination and participation in cervical cancer screening among a nationally representative sample of women in the United States.

Methods: We utilized data from the National Survey of Family Growth for the years 2015-2019 focusing on women aged 18-24 vaccinated against HPV.

Variation in cervical cancer screening test utilization and results in a United States-based program.

Background: Little is known about cervical cancer screening strategy utilization (cytology alone, cytology plus high-risk human papillomavirus [HPV] testing [cotesting], primary HPV testing) and test results in the United States.

Methods: Data from the Centers for Disease Control and Prevention's National Breast and Cervical Cancer Early Detection Program were analyzed for 199,578 persons aged 21-65 years screened from 2019 to 2020. Screening test utilization and results were stratified by demographic characteristics and geographic region.

The association between YouTube use and knowledge of human papillomavirus-related cancers.

Objective: To examine the association between YouTube usage and HPV-related cancer knowledge (cervical, anal, oral and penile).

Study Design: Cross-sectional study using data from the Health Information National Trends survey conducted between 2017 and 2020 ( = 16,092). Logistic regression was used to analyze the independent effect of YouTube use on cancer knowledge, controlling for sociodemographic characteristics.

Avoiding Low-Value Care and Patient Financial Harm in Cervical Cancer Screening.

The provision of low-value care remains a significant concern in healthcare. The negative impacts resulting from low-value cervical cancer screenings are extensive at the population level and can lead to harms and substantial out-of-pocket expenses for patients. Inattention to the financial implications of screening poses a serious threat to low-income populations that depend on affordable screening services, and it may exacerbate existing healthcare disparities and inequities.